Literature DB >> 19288270

Substantially reduced expression of PIAS1 is associated with colon cancer development.

Domenico Coppola1, Vevek Parikh, David Boulware, George Blanck.   

Abstract

PURPOSE: Protein inhibitors of activated STATs (PIAS) regulate the interferon-gamma (IFN-gamma) signaling pathway, which has numerous effects on tumor development and tumor cell biology. PIAS's also regulate STAT family members not directly involved in IFN-gamma signaling. This project was designed to assess PIAS1 expression in colon cancer.
METHODS: To determine whether PIAS1, one of the PIAS family members, or IFN-gamma signaling pathway components could be used to stratify colon tumors, we stained tissue microarrays for PIAS1, interferon regulatory factor-1 (IRF-1) and STAT1alpha.
RESULTS: PIAS1 staining of the colon cancer tissue microarrays indicated a strong correlation of normal colon cells, and adenomas, with high expression of both PIAS1 and IRF-1.
CONCLUSION: The PIAS1 results in particular may represent a basis for new approaches for efficiently distinguishing adenomas from colon cancer.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19288270     DOI: 10.1007/s00432-009-0570-z

Source DB:  PubMed          Journal:  J Cancer Res Clin Oncol        ISSN: 0171-5216            Impact factor:   4.553


  14 in total

1.  A generalized Sidak-Holm procedure and control of generalized error rates under independence.

Authors:  Wenge Guo; Joseph Romano
Journal:  Stat Appl Genet Mol Biol       Date:  2007-01-25

Review 2.  PIAS proteins as regulators of small ubiquitin-related modifier (SUMO) modifications and transcription.

Authors:  J J Palvimo
Journal:  Biochem Soc Trans       Date:  2007-12       Impact factor: 5.407

3.  Physiological and receptor-selective retinoids modulate interferon gamma signaling by increasing the expression, nuclear localization, and functional activity of interferon regulatory factor-1.

Authors:  Xin M Luo; A Catharine Ross
Journal:  J Biol Chem       Date:  2005-08-05       Impact factor: 5.157

Review 4.  Stimulation of interferon regulatory factor-1 by prolactin.

Authors:  L Yu-Lee
Journal:  Lupus       Date:  2001       Impact factor: 2.911

5.  Interferon regulatory factor-1 and -2 expression in human melanoma specimens.

Authors:  J K Lowney; L D Boucher; P E Swanson; G M Doherty
Journal:  Ann Surg Oncol       Date:  1999-09       Impact factor: 5.344

6.  Co-occupancy of the interferon regulatory element of the class II transactivator (CIITA) type IV promoter by interferon regulatory factors 1 and 2.

Authors:  H Xi; D D Eason; D Ghosh; S Dovhey; K L Wright; G Blanck
Journal:  Oncogene       Date:  1999-10-21       Impact factor: 9.867

7.  High level class II trans-activator induction does not occur with transient activation of the IFN-gamma signaling pathway.

Authors:  D D Eason; G Blanck
Journal:  J Immunol       Date:  2001-01-15       Impact factor: 5.422

8.  Interferon regulatory factor-1 (IRF-1) exhibits tumor suppressor activities in breast cancer associated with caspase activation and induction of apoptosis.

Authors:  Kerrie B Bouker; Todd C Skaar; Rebecca B Riggins; David S Harburger; David R Fernandez; Alan Zwart; Antai Wang; Robert Clarke
Journal:  Carcinogenesis       Date:  2005-05-05       Impact factor: 4.944

9.  Interferon-gamma induces Ice gene expression and enhances cellular susceptibility to apoptosis in the U937 leukemia cell line.

Authors:  T Tamura; S Ueda; M Yoshida; M Matsuzaki; H Mohri; T Okubo
Journal:  Biochem Biophys Res Commun       Date:  1996-12-04       Impact factor: 3.575

10.  Requirement of histone deacetylase activity for signaling by STAT1.

Authors:  Lidija Klampfer; Jie Huang; Laurie-Anne Swaby; Leonard Augenlicht
Journal:  J Biol Chem       Date:  2004-05-03       Impact factor: 5.157

View more
  15 in total

Review 1.  SUMO and the robustness of cancer.

Authors:  Jacob-Sebastian Seeler; Anne Dejean
Journal:  Nat Rev Cancer       Date:  2017-01-30       Impact factor: 60.716

2.  NF-κB and cancer: a paradigm of Yin-Yang.

Authors:  Gutian Xiao; Jing Fu
Journal:  Am J Cancer Res       Date:  2010-12-06       Impact factor: 6.166

3.  Integrated analyses of genome-wide DNA occupancy and expression profiling identify key genes and pathways involved in cellular transformation by a Marek's disease virus oncoprotein, Meq.

Authors:  Sugalesini Subramaniam; John Johnston; Likit Preeyanon; C Titus Brown; Hsing-Jien Kung; Hans H Cheng
Journal:  J Virol       Date:  2013-06-05       Impact factor: 5.103

4.  QUANTITATIVE MORPHOLOGICAL AND MOLECULAR PATHOLOGY OF THE HUMAN THYMUS CORRELATE WITH INFANT CAUSE OF DEATH.

Authors:  Mark C Lloyd; Nancy Burke; Fatemeh Kalantarpour; Melissa I Niesen; Aaron Hall; Keith Pennypacker; Bruce Citron; Chaim G Pick; Vernard Adams; Mahasweta Das; Shyam Mohapatra; Hernani Cualing; George Blanck
Journal:  Technol Innov       Date:  2014

5.  A systems biology approach to the global analysis of transcription factors in colorectal cancer.

Authors:  Meeta P Pradhan; Nagendra K A Prasad; Mathew J Palakal
Journal:  BMC Cancer       Date:  2012-08-01       Impact factor: 4.430

6.  A signature inferred from Drosophila mitotic genes predicts survival of breast cancer patients.

Authors:  Christian Damasco; Antonio Lembo; Maria Patrizia Somma; Maurizio Gatti; Ferdinando Di Cunto; Paolo Provero
Journal:  PLoS One       Date:  2011-02-28       Impact factor: 3.240

7.  PIAS1-modulated Smad2/4 complex activation is involved in zinc-induced cancer cell apoptosis.

Authors:  N Yang; B Zhao; A Rasul; H Qin; J Li; X Li
Journal:  Cell Death Dis       Date:  2013-09-19       Impact factor: 8.469

8.  PIAS1 is a crucial factor for prostate cancer cell survival and a valid target in docetaxel resistant cells.

Authors:  Martin Puhr; Julia Hoefer; Hannes Neuwirt; Iris E Eder; Johann Kern; Georg Schäfer; Stephan Geley; Isabel Heidegger; Helmut Klocker; Zoran Culig
Journal:  Oncotarget       Date:  2014-12-15

9.  Identification of the SUMO E3 ligase PIAS1 as a potential survival biomarker in breast cancer.

Authors:  Ayan Chanda; Angela Chan; Lili Deng; Elizabeth N Kornaga; Emeka K Enwere; Donald G Morris; Shirin Bonni
Journal:  PLoS One       Date:  2017-05-11       Impact factor: 3.240

10.  PD-L1 upregulation is associated with activation of the DNA double-strand break repair pathway in patients with colitic cancer.

Authors:  Naoya Ozawa; Takehiko Yokobori; Katsuya Osone; Chika Katayama; Kunihiko Suga; Chika Komine; Yuta Shibasaki; Takuya Shiraishi; Takuhisa Okada; Ryuji Kato; Hiroomi Ogawa; Akihiko Sano; Makoto Sakai; Makoto Sohda; Hitoshi Ojima; Tatsuya Miyazaki; Yoko Motegi; Munenori Ide; Takashi Yao; Hiroyuki Kuwano; Ken Shirabe; Hiroshi Saeki
Journal:  Sci Rep       Date:  2021-06-22       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.